Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Terbinafine surpasses comparators for clearing onychomycosis
New Orleans - In the treatment of onychomycosis, terbinafine (Lamisil) offers better short-term and long-term efficacy relative to other oral antifungal agents, Bernard J. Cribier, M.D., Ph.D., said at the annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
